GLP-1 Receptor Agonists

GLP‑1 Drugs Move into the Mainstream as UK Clears Oral Wegovy and Tirzepatide Shows Bigger Weight Loss

Regulatory approval of an oral semaglutide pill plus new comparative data could accelerate use and expose gaps in response, safety and access in obesity care.